Home LiteratureArticle Details
PMID: 20103567 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Post-translational modifications differentially affect IgG1 conformation and receptor binding.

Molecular & cellular proteomics : MCP ·Vol. 9 ·No. 8 ·2010-08-00 ·Pages 1716-28

Houde D, Peng Y, Berkowitz SA, Engen JR

Abstract

Post-translational modifications (PTMs) can have profound effects on protein structure and protein dynamics and thereby can influence protein function. To understand and connect PTM-induced functional differences with any resulting conformational changes, the conformational changes must be detected and localized to specific parts of the protein. We illustrate these principles here with a study of the functional and conformational changes that accompany modifications to a monoclonal immunoglobulin gamma1 (IgG1) antibody. IgG1s are large and heterogeneous proteins capable of incorporating a multiplicity of PTMs both in vivo and in vitro. For many IgG1s, these PTMs can play a critical role in affecting conformation, biological function, and the ability of the antibody to initiate a potential adverse biological response. We investigated the impact of differential galactosylation, methionine oxidation, and fucosylation on solution conformation using hydrogen/deuterium exchange mass spectrometry and probed the effects of IgG1 binding to the FcgammaRIIIa receptor. The results showed that methionine oxidation and galactosylation both impact IgG1 conformation, whereas fucosylation appears to have little or no impact to the conformation. FcgammaRIIIa binding was strongly influenced by both the glycan structure/composition (namely galactose and fucose) and conformational changes that were induced by some of the modifications.

MeSH Terms
Amino Acid Sequence Animals CHO Cells Cricetinae Cricetulus Deuterium Glycosylation Humans Immunoglobulin G/chemistry,metabolism Mass Spectrometry Models, Molecular Molecular Sequence Data Mutant Proteins/chemistry,metabolism Protein Processing, Post-Translational Protons Receptors, Fc/metabolism
Chemicals
Immunoglobulin G Mutant Proteins Protons Receptors, Fc Deuterium
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Houde Damian
Biogen Idec, Inc., Cambridge, Massachusetts 02142, USA.
Peng Yucai
Berkowitz Steven A
Engen John R
References (49)
49 references, click to expand
  1. Semi-automated data processing of hydrogen exchange mass spectra using HX-Express.
    J Am Soc Mass Spectrom. 2006 Dec;17(12):1700-3 PMID: 16931036
  2. Contribution of variable domains to the stability of humanized IgG1 monoclonal antibodies.
    J Pharm Sci. 2008 Apr;97(4):1414-26 PMID: 17721938
  3. Glycoform-dependent conformational alteration of the Fc region of human immunoglobulin G1 as revealed by NMR spectroscopy.
    Biochim Biophys Acta. 2006 Apr;1760(4):693-700 PMID: 16343775
  4. A comparison of ALPHAScreen, TR-FRET, and TRF as assay methods for FXR nuclear receptors.
    J Biomol Screen. 2002 Feb;7(1):3-10 PMID: 11897050
  5. Determination of protein oxidation by mass spectrometry and method transfer to quality control.
    J Chromatogr A. 2006 Aug 11;1123(2):189-98 PMID: 16716331
  6. Solution NMR of supramolecular complexes: providing new insights into function.
    Nat Methods. 2007 Sep;4(9):697-703 PMID: 17762877
  7. In vitro galactosylation of human IgG at 1 kg scale using recombinant galactosyltransferase.
    Biotechnol Bioeng. 2005 Dec 30;92(7):831-42 PMID: 16187338
  8. Structural comparison of fucosylated and nonfucosylated Fc fragments of human immunoglobulin G1.
    J Mol Biol. 2007 May 4;368(3):767-79 PMID: 17368483
  9. Assessment of the repeatability and reproducibility of hydrogen/deuterium exchange mass spectrometry measurements.
    Rapid Commun Mass Spectrom. 2008 Dec;22(23):3893-901 PMID: 19003828
  10. Potent antibody therapeutics by design.
    Nat Rev Immunol. 2006 May;6(5):343-57 PMID: 16622479
  11. Fucose depletion from human IgG1 oligosaccharide enhances binding enthalpy and association rate between IgG1 and FcgammaRIIIa.
    J Mol Biol. 2004 Mar 5;336(5):1239-49 PMID: 15037082
  12. Role of oligosaccharide residues of IgG1-Fc in Fc gamma RIIb binding.
    J Biol Chem. 2001 Dec 7;276(49):45539-47 PMID: 11567028
  13. Oxidizable residues mediating protein stability and cytoprotective interaction of DJ-1 with apoptosis signal-regulating kinase 1.
    J Biol Chem. 2009 May 22;284(21):14245-57 PMID: 19293155
  14. Oxidation of calmodulin alters activation and regulation of CaMKII.
    Biochem Biophys Res Commun. 2007 Apr 27;356(1):97-101 PMID: 17343827
  15. Variations in oligosaccharide-protein interactions in immunoglobulin G determine the site-specific glycosylation profiles and modulate the dynamic motion of the Fc oligosaccharides.
    Biochemistry. 1997 Feb 11;36(6):1370-80 PMID: 9063885
  16. Identification of protein-protein interfaces by decreased amide proton solvent accessibility.
    Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14705-10 PMID: 9843953
  17. Probing the non-covalent structure of proteins by amide hydrogen exchange and mass spectrometry.
    J Mass Spectrom. 1997 Feb;32(2):135-46 PMID: 9102198
  18. Mass spectrometry-based proteomics.
    Nature. 2003 Mar 13;422(6928):198-207 PMID: 12634793
  19. Recognition of immunoglobulins by Fcgamma receptors.
    Mol Immunol. 2002 May;38(14):1073-83 PMID: 11955599
  20. The 3.2-A crystal structure of the human IgG1 Fc fragment-Fc gammaRIII complex.
    Nature. 2000 Jul 20;406(6793):267-73 PMID: 10917521
  21. Post-translational modifications in the context of therapeutic proteins.
    Nat Biotechnol. 2006 Oct;24(10):1241-52 PMID: 17033665
  22. IgG-Fc-mediated effector functions: molecular definition of interaction sites for effector ligands and the role of glycosylation.
    Immunol Rev. 1998 Jun;163:59-76 PMID: 9700502
  23. The influence of glycosylation on the thermal stability and effector function expression of human IgG1-Fc: properties of a series of truncated glycoforms.
    Mol Immunol. 2000 Aug-Sep;37(12-13):697-706 PMID: 11275255
  24. Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity.
    J Mol Biol. 2003 Jan 31;325(5):979-89 PMID: 12527303
  25. Speeding molecular recognition by using the folding funnel: the fly-casting mechanism.
    Proc Natl Acad Sci U S A. 2000 Aug 1;97(16):8868-73 PMID: 10908673
  26. Protein posttranslational modifications: the chemistry of proteome diversifications.
    Angew Chem Int Ed Engl. 2005 Dec 1;44(45):7342-72 PMID: 16267872
  27. Analysis of protein complexes with hydrogen exchange and mass spectrometry.
    Analyst. 2003 Jun;128(6):623-8 PMID: 12866878
  28. High-speed and high-resolution UPLC separation at zero degrees Celsius.
    Anal Chem. 2008 Sep 1;80(17):6815-20 PMID: 18672890
  29. The effect of the removal of sialic acid, galactose and total carbohydrate on the functional activity of Campath-1H.
    Mol Immunol. 1995 Dec;32(17-18):1311-8 PMID: 8643100
  30. Analysis of protein conformation and dynamics by hydrogen/deuterium exchange MS.
    Anal Chem. 2009 Oct 1;81(19):7870-5 PMID: 19788312
  31. The structure of a human type III Fcgamma receptor in complex with Fc.
    J Biol Chem. 2001 May 11;276(19):16469-77 PMID: 11297532
  32. A broad range of Fab stabilities within a host of therapeutic IgGs.
    Biochem Biophys Res Commun. 2007 Apr 13;355(3):751-7 PMID: 17321501
  33. The impact of glycosylation on the biological function and structure of human immunoglobulins.
    Annu Rev Immunol. 2007;25:21-50 PMID: 17029568
  34. Increasing the precision of comparative models with YASARA NOVA--a self-parameterizing force field.
    Proteins. 2002 May 15;47(3):393-402 PMID: 11948792
  35. Hydrogen exchange mass spectrometry for the analysis of protein dynamics.
    Mass Spectrom Rev. 2006 Jan-Feb;25(1):158-70 PMID: 16208684
  36. Crystal structure of a neutralizing human IGG against HIV-1: a template for vaccine design.
    Science. 2001 Aug 10;293(5532):1155-9 PMID: 11498595
  37. Mass spectrometric determination of isotopic exchange rates of amide hydrogens located on the surfaces of proteins.
    Anal Chem. 1996 Jul 15;68(14):2340-4 PMID: 8686927
  38. Determination of protein structures--a series of fortunate events.
    Biophys J. 2008 Jul;95(1):1-9 PMID: 18441029
  39. Impact of methionine oxidation on the binding of human IgG1 to Fc Rn and Fc gamma receptors.
    Mol Immunol. 2009 May;46(8-9):1878-82 PMID: 19269032
  40. Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-A resolution.
    Biochemistry. 1981 Apr 28;20(9):2361-70 PMID: 7236608
  41. Non-fucosylated therapeutic antibodies as next-generation therapeutic antibodies.
    Expert Opin Biol Ther. 2006 Nov;6(11):1161-73 PMID: 17049014
  42. Absolute quantification of proteins by LCMSE: a virtue of parallel MS acquisition.
    Mol Cell Proteomics. 2006 Jan;5(1):144-56 PMID: 16219938
  43. Physicochemical and biological assays for quality control of biopharmaceuticals: interferon alpha-2 case study.
    Biologicals. 2008 Nov;36(6):383-92 PMID: 18691904
  44. Glycosylation as a strategy to improve antibody-based therapeutics.
    Nat Rev Drug Discov. 2009 Mar;8(3):226-34 PMID: 19247305
  45. Characterization of IgG1 conformation and conformational dynamics by hydrogen/deuterium exchange mass spectrometry.
    Anal Chem. 2009 Apr 1;81(7):2644-51 PMID: 19265386
  46. How to measure and predict the molar absorption coefficient of a protein.
    Protein Sci. 1995 Nov;4(11):2411-23 PMID: 8563639
  47. The effects of phosphorylation on the structure and function of proteins.
    Annu Rev Biophys Biomol Struct. 1993;22:199-232 PMID: 8347989
  48. Solution NMR of large molecules and assemblies.
    Biochemistry. 2007 Jan 16;46(2):331-40 PMID: 17209543
  49. Structure and stability changes of human IgG1 Fc as a consequence of methionine oxidation.
    Biochemistry. 2008 May 6;47(18):5088-100 PMID: 18407665
Article Info
Journal
Molecular & cellular proteomics : MCP
Abbr.
Mol Cell Proteomics
ISSN
1535-9484
Published
2010-08-00
Epub
2010-00-26
Pages
1716-28
Language
English
Region
United States
NLM ID
101125647
PMCID
PMC2938052
Subset
IM
Grants
NIGMS NIH HHS · R01 GM070590 · United States
NIGMS NIH HHS · R01 GM086507 · United States
NIGMS NIH HHS · GM-070590 · United States
NIGMS NIH HHS · GM-086507 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com